Method for absorption of acid gases
Abstract
The invention relates to a method for the absorption of acid gases, such as CO2 and H2S, from gas mixtures. According to the invention, acid gases are absorbed from a gas mixture by contacting this gas mixture with a liquid in which is dissolved so high a concentration of an amino acid or a salt thereof that a precipitate is formed. The contact takes place in a column of the packing-free type or a column suitable for processing slurries.

Term
Term ended
Expired 7 May 2023, 3.4 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
5 claims: 2 independent, 3 dependent
- 1A method for absorbing acid gases from a gas mixture by contacting this gas mixture with a liquid in which is dissolved so high a concentration of an amino acid or a salt thereof that after reaction with the acid gas components, the amino acid or one of the reaction products crystallizes, characterized in that the contact takes place in a column of the packing-free type or a column with a packing suitable to be driven with slurries.
- 3A method according to any one of the preceding claims, wherein the gas mixture to be cleaned contains H 2 S and CO 2 and wherein said amino acid or salt thereof is a sterically hindered amino acid or salt thereof.
Independent claims2
28 paragraphs in 1 section, as filed
0001The invention relates to a new method for the absorption of acid gases, such as CO<sub>2</sub> and H<sub>2</sub>S, from gas mixtures.
0002Emission of acid gases is detrimental to the environment. CO<sub>2</sub> causes the so-called greenhouse effect. H<sub>2</sub>S is damaging to health, causes stench nuisance and can form acid rain. In the state of the art, many methods for selectively removing acid gases from gas mixtures have already been described. A frequently used method is a gas treatment process in which the acid gases are absorbed in a liquid. Also, it has long since been known (for instance from <patcit id="pcit0001" dnum="US1990217A"><text>US-A-1 990 217</text></patcit>, <patcit id="pcit0002" dnum="US2176441A"><text>US-A-2 176 441</text></patcit> and <patcit id="pcit0003" dnum="US3042483A"><text>US-A-3 042 483</text></patcit>) that weakly acid gases, such as CO<sub>2</sub>, can be removed from gas mixtures by washing with a solution of imino acids, amino acids or tertiary N-acids or salts thereof. These publications show that, preferably, solutions with a high concentration of these acids or salts should be taken up. However, at high concentrations it is experienced as a drawback that precipitates of the acids, salts and/or reaction products are formed.
0003An adapted method for absorption of CO<sub>2</sub> is described in <patcit id="pcit0004" dnum="US5749941A"><text>US-A-5 749 941</text></patcit>, in which the gas mixture and the absorption liquid (i.e. a solution of amino salts) are separated by a hydrophobic membrane over which the gas exchange takes place. Here, too, a high concentration of amino salts is preferable, but physically impossible, because precipitation of the amino acids causes clogging of the membrane.
0004Now the invention comprises a method for absorbing acid gases from a gas mixture by contacting this gas mixture with a liquid in which is dissolved so high a concentration of an amino acid or a salt thereof that the amino acid or one of the other reaction products crystallizes after reaction with the acid gas components, characterized in that the contact takes place in a column of the packing-free type or a column with a packing suitable to be driven with slurries.
0005An advantage of this method is that higher concentrations of amino acids or amino salts are possible, so that a higher loading of the absorption liquid becomes possible. Besides, the CO<sub>2</sub> equilibrium pressure rises with the loading, also in a solution in which precipitate is formed.
0006The reaction of the amino acids or amino salts in solution with the passed-through CO<sub>2</sub> proceeds according to the following reaction scheme: 2RNH<sub>2</sub> + CO<sub>2</sub> → RNHCO<sub>2</sub><sup>-</sup> + RNH<sub>3</sub><sup>+</sup> (1) in which half of the amino acid present in the solution reacts with CO<sub>2</sub> to form carbamate. At sufficiently high concentration the amino acid will crystallize (RNH<sub>3</sub>+↓), so that the equilibrium of reaction (1) will shift to right. Besides, the carbamate formed can undergo hydrolysis according to: RNHCO<sub>2</sub><sup>-</sup> + H<sub>2</sub>O → HCO<sub>3</sub><sup>-</sup> + RNH<sub>2</sub> (2) wherein the bicarbonate formed can form salts, which also precipitate.
0007The reaction with H<sub>2</sub>S proceeds analogously: RNH<sub>2</sub> + H<sub>2</sub>S → HS<sup>-</sup> + RNH<sub>3</sub><sup>+</sup> (3)
0008In this case, too, the amino acid (RNH<sub>3</sub><sup>+</sup>) will crystallize. The bisulfide (HS-) remains in solution.
0009The drawback as described in the state of the art in that a precipitate of amino acid is formed is removed according to the invention by allowing this reaction to take place in a column in which the precipitate cannot cause damage to packings or other construction material. Thus, the reaction should preferably take place in a column without packings, for instance a spray column or a plate column.
0010It is thus possible to readily remove from the column the precipitate formed as a slurry on the bottom of the column, to optionally degas it outside the column and to return it as purified amino acid to the initial solution.
0011According to the present invention, a much higher concentration of the amino salt in the solution is possible, and consequently, more CO<sub>2</sub> can be stripped from the gas phase. This effect is enhanced because the equilibrium of the reaction shifts to right.
0012Also, the CO<sub>2</sub> can be readily removed outside the column from the CO<sub>2</sub>-saturated liquid (with any crystallized, but not yet precipitated amino acid).
0013The regeneration step may, for instance, be carried out by a direct regeneration of the slurry. In this direct regeneration, the temperature of the slurry is increased so that, on the one hand, the CO<sub>2</sub> goes out of solution and, on the other hand, the precipitate goes into solution again. Both processes strengthen each other. Even if the temperature is not increased, this process proceeds, if slowly. This embodiment of the regeneration step is particularly favorable if the precipitate consists of bicarbonate or a carbonate compound, because CO<sub>2</sub> is then bound in the precipitate.
0014Another possibility of carrying out the regeneration step is separation of the slurry into a liquid fraction containing CO<sub>2</sub> and a thickened liquid containing the amino acid, so that the regeneration step can be carried out with a smaller amount of liquid, which results in a saving of energy. The liquid may be subjected to a thermic regeneration. This embodiment is particularly suitable if the precipitate consists essentially of precipitated amino acids.
0015Because outside the column no CO<sub>2</sub> vapor tension is present above the liquid, the CO<sub>2</sub> will diffuse from the liquid via the reverse reaction of (1). The crystallized amino acid will thus go into solution again and cause the equilibrium of the reaction (1) to shift further to left, in which process more CO<sub>2</sub> will be removed from the carbamate and will diffuse from the liquid. This process can be accelerated by heating the liquid. The effects of heating are double: a higher driving force for desorption is obtained, and faster reactions and a faster substance transfer occur when the temperature rises. The thus CO<sub>2</sub>-depleted uranium can then be returned to the column again.
0016As amino salts, all conventional water-soluble salts of amino acids can be used. Amino acids are defined herein as all organic substances which contain one or more amine groups and one or more carboxylic acid groups or sulfonic acid groups. The acid groups can be bound to one and the same atom of the organic substance (as is the case with the naturally occurring amino acids) or to different atoms. Preferably used are amino acids of which the amine group is removed from the acid group by at least two or more atoms, such as carbon atoms.
0017Amino acids according to the invention can be subdivided into amino acids not having an internal steric hindrance (with respect to the accessibility for the amine group) and the amino acids having an internal steric hindrance. To remove only CO<sub>2</sub>, the amino acids without steric hindrance are preferably used, because they react with CO<sub>2</sub> according to reaction (1). Examples of non-sterically hindered amino acids according to the invention are taurine, methyl taurine, methyl-α-aminopropionic acid, N-(β-ethoxy)taurine and N-(β-aminoethyl)taurine, as well as all other amino acids described in <patcit id="pcit0005" dnum="US3042483A"><text>US-A-3 042 483</text></patcit>.
0018In the case of sterically hindered amino acids, the absorption of CO<sub>2</sub> goes via the formation of bicarbonate according to the following reaction mechanism: RNH<sub>2</sub><sup>-</sup> + CO<sub>2</sub> + H<sub>2</sub>O → HCO<sub>3</sub><sup>-</sup> + RNH<sub>3</sub><sup>+</sup> (4)
0019Here, too, the precipitate formation offers the advantage that the equilibrium of the reaction shifts to right and that thus, on balance, more CO<sub>2</sub> will be absorbable. Besides, the bicarbonate can form salts, which also precipitate.
0020If the gas mixture to be cleaned contains both H<sub>2</sub>S and CO<sub>2</sub>, a sterically hindered amino acid is advantageously used. Because H<sub>2</sub>S reacts faster than CO<sub>2</sub> with the amino acid, kinetic selectivity is obtained with respect to H<sub>2</sub>S. The reaction terminates through the crystallization, and the amino acid crystals can be filtered off, while the remaining bisulfide solution can be processed further, for instance electrochemically or oxidatively. The amino acid can be reused, without the necessity of subjecting it to a thermic regeneration step. As a result, no special requirements need to be imposed on the amino acid with respect to the thermic stability.
0021Examples of sterically hindered amino acids are the naturally occurring amino acids (the amino acids which are part of naturally occurring proteins), in which the accessibility of the amino group is limited by the presence of a carboxylic acid group at the same C atom. Examples thereof are analine and glycine and derivatives thereof, such as N-methyl analine and dimethyl glycine. Aqueous solutions with such amino acids are commercially available under the tradenames of Alkazyd N (analine), Alkazyd M (N-methyl analine) and Alkazyd di-K (dimethyl glycine). It is also possible to use amino acids containing several amine groups per molecule, such as asparagine, glutamine, lysine and histidine.
0022The sterically hindered amino acids and their salts will absorb the CO<sub>2</sub> in a ratio of 1 mol CO<sub>2</sub> per mol amino group; with the non-sterically hindered amino acids and their salts the ratio is 0.5:1 because of the carbamate remaining in solution. However, the non-sterically hindered amino acids and salts offer the advantage that they generally have a lower binding energy for CO<sub>2</sub> and are thus easier to regenerate.
0023The amino salts are preferably salts with potassium or sodium, potassium being preferred.
0024Preferred for the invention are solutions of amino salts, because they are more soluble at a higher concentration than the corresponding amino acid. Preferably used are concentrations at which the salt is soluble, but at-which the corresponding amino acid crystallizes as a result of the reaction with the CO<sub>2</sub>. With the aid of, for instance, NaOH or KOH, the pH of the solution of the salt will be brought to an alkaline value, preferably a pH of 9-13, because the alkaline environment provides the availability of the amino groups in a free, that is to say non-protonated form.
0025Preferably used is a solution of potassium taurate in which the solution contains a concentration of more than 0.2 mol/l of the salt.
EXAMPLE
0026Solutions of 0.5, 1.0, 2.0, 3.0 and 4.0 M potassium taurate were prepared by neutralizing the corresponding amino acid (taurine, Merck) dissolved in deionized water with a slightly less than equimolar, known amount of KOH (Merck). The remaining amount of KOH was added by potentiometrically titrating the solution using an aqueous KOH solution of known strength. The adjusted concentrations were verified by means of back titration of samples of the solutions with standard HCl solutions. The solutions (in each case about 500 ml) were tested in a double-walled glass vessel (content about 1.6 dm<sup>3</sup>), a dilute CO<sub>2</sub> gas stream flowing through the solution under vigorous agitation. The concentration of CO<sub>2</sub> was varied from 0-6.0 vol.% to carry out the measurements shown in <figref idref="f0001">Fig. 1</figref>. The tests were carried out at a temperature of 25°C. The CO<sub>2</sub> concentration was continuously measured by means of an IR gas analyzer, during which switching was effected between effluent and feed. Each test was carried out until equilibrium was attained (inlet and outlet CO<sub>2</sub> concentration equal).
0027<figref idref="f0001">Fig. 1</figref> shows the amount of absorbed CO<sub>2</sub> expressed in mol CO<sub>2</sub> per mol amine (α) plotted against the partial CO<sub>2</sub> tension of the superjacent atmosphere expressed in kPa. Visible is that the measurements belonging to the concentrations of 0.5 and 1.0 M salt get satisfied at an α of respectively 0.55 and 0.6. This is explainable because the amine is responsible for an absorption of 0.5 mol CO<sub>2</sub> per mol amine, the residual value of α being explained because CO<sub>2</sub> also itself partially dissolves in water. With the 2M solution, flattening of the curve takes place at an α of 0.55, which is explained because at that moment the taurine in the solution crystallizes so that a virtually higher loading proves possible. With the solutions of 3 and 4M salt, crystallization occurs already earlier, and α=0.5 is reached while a partial CO<sub>2</sub> tension has hardly been attained yet.
0028This shows that through the crystallization of the amino acid a higher CO<sub>2</sub> loading is possible.
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| US1990217A | Cites | United States of America |
| US3042483A | Cites | United States of America |
| US3660016A | Cites | United States of America |
22 members in 15 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 1020560 | Netherlands (Kingdom of the) | – | |
| 1020560 | Netherlands (Kingdom of the) | A | |
| 0300337 | Netherlands (Kingdom of the) | W |
Members22
| Document | Office | Kind | |
|---|---|---|---|
| AU2003228142A1 | Australia | A1 | |
| NL1020560C2 | Netherlands (Kingdom of the) | C2 | |
| CA2484650A1 | Canada | A1 | |
| WO03095071A1 | World Intellectual Property Organization (WIPO) | A1 | |
| KR20050007477A | Republic of Korea | A | |
| EP1501620A1 | European Patent Office (EPO) | A1 | |
| NO20044839L | Norway | L | |
| CN1652861A | China | A | |
| JP2005524526A | Japan | A | |
| NZ536472A | New Zealand | A | |
| US2006117954A1 | United States of America | A1 | |
| EP1501620B1This record | European Patent Office (EPO) | B1 | |
| AT415192T | Austria | T | |
| ATE415192T1 | Austria | T1 | |
| DE60324912D1 | Germany | D1 | |
| AU2003228142B2 | Australia | B2 | |
| DK1501620T3 | Denmark | T3 | |
| AU2003228142B8 | Australia | B8 | |
| CA2484650C | Canada | C | |
| US7927403B2 | United States of America | B2 | |
| NO331311B1 | Norway | B1 | |
| BRPI0309822A2 | Brazil | A2 |
60 legal events, as 9 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | NL | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1501620
- Application
- 37258803
Titles3
- German
- VERFAHREN ZUR ABSORPTION VON SAUREN GASEN
- English
- METHOD FOR ABSORPTION OF ACID GASES
- French
- PROCEDE D'ABSORPTION DE GAZ ACIDES
Classification
- CPC, 6
- B01D53/62
- B01D53/14
- B01D53/1456
- B01D53/1493
- B01D53/52
- Y02C20/40
- IPC, 6
- B01D53 14
- B01D53 62
- B01D53 52
- B01D53 50
- B01D53 18
- B01D53 77
Designated states27
- Contracting states, 27
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Romania
- Sweden
and 3 moreShow fewer
- Slovenia
- Slovakia
- Türkiye